Member news

CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020

More at curevac.com…

Atriva Therapeutics Doses First Patient in Phase II RESPIRE trial in COVID-19

More at atriva-therapeutics.com…

Evotec launches 'beLAB2122', translating academic innovation from leading German life science region in collaboration with Bristol Myers Squibb

More at belab2122.org…

Expansion of Lonza’s Automated Robotic Solution for Endotoxin Testing Automates Sustainable Recombinant Factor C Assay

More at lonza.com…

CellGenix Appoints Daniel Spatz as Vice President Sales, Marketing & Logistics and Member of the Management Team

More at cellgenix.com…

Cellbox Solutions Announces New Headquarters

More at b3cnewswire.com…

Pieris Pharmaceuticals Presents Updated Phase 1 Monotherapy Data for 4-1BB/HER2 Bispecific Cinrebafusp Alfa and Preclinical Data for 4-1BB/PD-L1 Bispecific PRS-344/S095012

More at pieris.com…

AACR data show characteristics of Medigene's lead TCR candidate against solid tumors

More at medigene.com…

Identification of ten novel tumor-specific antigens immunogenic for T cells

More at medigene.com…

CureVac to Report Fourth Quarter and Full-Year 2020 Financial Results and Business Updates on April 15, 2021

More at curevac.com…

Evotec and Exscientia announce start of human clinical trials of novel immuno-oncology drug

More at evotec.com…

Metriopharm: Long-term Toxicology Studies Confirm Very Good Safety Profile of MP1032

More at archive.newsletter2go.com…

Biomax Informatics presents AILANI 2.0 for even more intelligent responses

More at biomax.com…

Medigene: Participation at upcoming virtual conferences

More at medigene.com…

PAION announces product launch of BYFAVO (REMIMAZOLAM) in South Korea by HANA PHARM

More at paion.com…

Better performance characteristics of Epigenomics’ liver cancer panel compared to the current standard of care for the early detection of HCC

More at epigenomics.com…

Arbutus Biopharma, X-Chem and Proteros biostructures Enter into a Pan-Coronavirus DiscoveryResearch and License Agreement

More at investor.arbutusbio.com…

Biomax Informatics develops knowledge management solution NeuroCONNECTfor Human Brain Project

More at biomax.com…

Immunic and 4SC AG Sign Agreement Regarding the Settlement of Royalty Obligations for Immunic’s Lead Program, IMU-838

More at immunic-therapeutics.com…

Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation

More at rentschler-biopharma.com…

Heidelberg Pharma to Present New Data on its Proprietary ATAC Technology Platform at the AACR Annual Meeting 2021

More at heidelberg-pharma.com…

Medigene: Publication of research on co-receptor independent MAGE-A4-specific T cell receptor

More at medigene.com…

PAION AG reports on successful fiscal year 2020

More at paion.com…

Celonic and CureVac Announce Agreement to Manufacture over 100 Million Doses of CureVac’s COVID-19 Vaccine Candidate, CVnCoV

More at b3cnewswire.com…

Pieris Pharmaceuticals Reports Full-Year 2020 Financial Results and Provides Corporate Update

More at pieris.com…

Plastic waste from c-LEcta laboratories gets second chance

More at c-lecta.com…

AiCuris expands its Management with Prof. Dr. Hubert Trübel as Chief Medical Officer and Dr. Tamara Pfaff, Head of Preclinical Development

More at aicuris.com…

Some childhood tumors start in early pregnancy

More at kitz-heidelberg.de…

Epigenomics AG Reports Financial Results for Fiscal Year 2020

More at epigenomics.com…

InflaRx Reports Full Year 2019 Financial & Operating Results

More at inflarx.de…